10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hypercholesterolemia downregulates autophagy in the rat heart

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          We have previously shown that efficiency of ischemic conditioning is diminished in hypercholesterolemia and that autophagy is necessary for cardioprotection. However, it is unknown whether isolated hypercholesterolemia disturbs autophagy or the mammalian target of rapamycin (mTOR) pathways. Therefore, we investigated whether isolated hypercholesterolemia modulates cardiac autophagy-related pathways or programmed cell death mechanisms such as apoptosis and necroptosis in rat heart.

          Methods

          Male Wistar rats were fed either normal chow (NORM; n = 9) or with 2% cholesterol and 0.25% cholic acid-enriched diet (CHOL; n = 9) for 12 weeks. CHOL rats exhibited a 41% increase in plasma total cholesterol level over that of NORM rats (4.09 mmol/L vs. 2.89 mmol/L) at the end of diet period. Animals were sacrificed, hearts were excised and briefly washed out. Left ventricles were snap-frozen for determination of markers of autophagy, mTOR pathway, apoptosis, and necroptosis by Western blot.

          Results

          Isolated hypercholesterolemia was associated with a significant reduction in expression of cardiac autophagy markers such as LC3-II, Beclin-1, Rubicon and RAB7 as compared to controls. Phosphorylation of ribosomal S6, a surrogate marker for mTOR activity, was increased in CHOL samples. Cleaved caspase-3, a marker of apoptosis, increased in CHOL hearts, while no difference in the expression of necroptotic marker RIP1, RIP3 and MLKL was detected between treatments.

          Conclusions

          This is the first comprehensive analysis of autophagy and programmed cell death pathways of apoptosis and necroptosis in hearts of hypercholesterolemic rats. Our data show that isolated hypercholesterolemia suppresses basal cardiac autophagy and that the decrease in autophagy may be a result of an activated mTOR pathway. Reduced autophagy was accompanied by increased apoptosis, while cardiac necroptosis was not modulated by isolated hypercholesterolemia. Decreased basal autophagy and elevated apoptosis may be responsible for the loss of cardioprotection reported in hypercholesterolemic animals.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.

          Tumor necrosis factor (TNF) is a pleiotropic molecule with a crucial role in cellular stress and inflammation during infection, tissue damage, and cancer. TNF signaling can lead to three distinct outcomes, each of which is initiated by different signaling complexes: the gene induction or survival mode, the apoptosis mode, and the necrosis mode. The kinases receptor-interacting protein 1 (RIP1) and RIP3 are key signaling molecules in necrosis and are regulated by caspases and ubiquitination. Moreover, TNF stimulation induces the formation of a necrosome in which RIP3 is activated and interacts with enzymes that control glycolytic flux and glutaminolysis. The necrosome induces mitochondrial complex I-mediated production of reactive oxygen species (ROS) and cytotoxicity, which suggest a functional link between increased bioenergetics and necrosis. In addition, other effector mechanisms also contribute to TNF-induced necrosis, such as recruitment of NADPH (the reduced form of nicotinamide adenine dinucleotide phosphate) oxidases and subsequent ROS production at the membrane-associated TNF receptor complex I; calcium mobilization; activation of phospholipase A(2), lipoxygenases, and acid sphingomyelinases; and lysosomal destabilization. However, the link between RIP1 and RIP3 and these subcellular events remains to be established. The regulation of RIP1 and RIP3 and their downstream signaling cascades opens new therapeutic avenues for treatment of pathologies associated with cell loss, such as ischemia-reperfusion damage and neurodegeneration, and ways to stimulate alternative immunogenic cell death pathways in cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes.

            Cardiac myocytes undergo programmed cell death as a result of ischemia/reperfusion (I/R). One feature of I/R injury is the increased presence of autophagosomes. However, to date it is not known whether macroautophagy functions as a protective pathway, contributes to programmed cell death, or is an irrelevant event during cardiac I/R injury. We employed simulated I/R of cardiac HL-1 cells as an in vitro model of I/R injury to the heart. To assess macroautophagy, we quantified autophagosome generation and degradation (autophagic flux), as determined by steady-state levels of autophagosomes in relation to lysosomal inhibitor-mediated accumulation of autophagosomes. We found that I/R impaired both formation and downstream lysosomal degradation of autophagosomes. Overexpression of Beclin1 enhanced autophagic flux following I/R and significantly reduced activation of pro-apoptotic Bax, whereas RNA interference knockdown of Beclin1 increased Bax activation. Bcl-2 and Bcl-x(L) were protective against I/R injury, and expression of a Beclin1 Bcl-2/-x(L) binding domain mutant resulted in decreased autophagic flux and did not protect against I/R injury. Overexpression of Atg5, a component of the autophagosomal machinery downstream of Beclin1, did not affect cellular injury, whereas expression of a dominant negative mutant of Atg5 increased cellular injury. These results demonstrate that autophagic flux is impaired at the level of both induction and degradation and that enhancing autophagy constitutes a powerful and previously uncharacterized protective mechanism against I/R injury to the heart cell.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oxidative stress stimulates autophagic flux during ischemia/reperfusion.

              Autophagy is a bulk degradation process in which cytosolic proteins and organelles are degraded through lysosomes. To evaluate autophagic flux in cardiac myocytes, we generated adenovirus and cardiac-specific transgenic mice harboring tandem fluorescent mRFP-GFP-LC3. Starvation significantly increased the number of mRFP-GFP-LC3 dots representing both autophagosomes and autolysosomes per cell, suggesting that autophagic flux is increased in cardiac myocytes. H(2)O(2) significantly increased autophagic flux, which was attenuated in the presence of N-2-mercaptopropionyl glycine (MPG), an antioxidant, suggesting that oxidative stress stimulates autophagy in cardiac myocytes. Myocardial ischemia/reperfusion (I/R) increased both autophagosomes and autolysosomes, thereby increasing autophagic flux. Treatment with MPG attenuated I/R-induced increases in oxidative stress, autophagic flux, and Beclin-1 expression, accompanied by a decrease in the size of myocardial infarction (MI)/area at risk (AAR), suggesting that oxidative stress plays an important role in mediating autophagy and myocardial injury during I/R. MI/AAR after I/R was significantly reduced in beclin1(+/-) mice, whereas beclin1(+/-) mice treated with MPG exhibited no additional reduction in the size of MI/AAR after I/R. These results suggest that oxidative stress plays an important role in mediating autophagy during I/R, and that activation of autophagy through oxidative stress mediates myocardial injury in response to I/R in the mouse heart.
                Bookmark

                Author and article information

                Contributors
                giricz.zoltan@med.semmelweis-univ.hu
                koncsos.gabor@med.semmelweis-univ.hu
                tomas.rajtik@gmail.com
                varga.zoltan@med.semmelweis-univ.hu
                baranyai.tamas@med.semmelweis-univ.hu
                csonka.csaba@med.u-szeged.hu
                adrian.szobi@gmail.com
                adameova@fpharm.uniba.sk
                Roberta.Gottlieb@cshs.org
                peter.ferdinandy@pharmahungary.com
                Journal
                Lipids Health Dis
                Lipids Health Dis
                Lipids in Health and Disease
                BioMed Central (London )
                1476-511X
                23 March 2017
                23 March 2017
                2017
                : 16
                : 60
                Affiliations
                [1 ]ISNI 0000 0001 0942 9821, GRID grid.11804.3c, Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, , Semmelweis University, ; Nagyvárad tér 4, H-1089 Budapest, Hungary
                [2 ]ISNI 0000 0001 1016 9625, GRID grid.9008.1, Department of Biochemistry, Faculty of Medicine, , University of Szeged, ; Dóm tér 9, H-6720 Szeged, Hungary
                [3 ]ISNI 0000000109409708, GRID grid.7634.6, Department of Pharmacology and Toxicology, Faculty of Pharmacy, , Comenius University, ; Odbojárov 10, 83232 Bratislava, Slovakia
                [4 ]ISNI 0000 0001 2152 9905, GRID grid.50956.3f, Heart Institute, , Cedars-Sinai Medical Center, ; 127 S. San Vicente Blvd., Los Angeles, CA 90048 USA
                [5 ]Pharmahungary Group, Szeged, Hungary
                Author information
                http://orcid.org/0000-0003-2036-8665
                Article
                455
                10.1186/s12944-017-0455-0
                5363032
                28330474
                09b3b45c-1ea6-4ea3-8776-aaf774153c65
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 16 December 2016
                : 14 March 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100003549, Országos Tudományos Kutatási Alapprogramok;
                Award ID: OTKA K109737
                Award Recipient :
                Funded by: Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic
                Award ID: VEGA 1/0638/12
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100003825, Magyar Tudományos Akadémia;
                Award ID: János Bolyai Research Scholarship
                Award ID: János Bolyai Research Scholarship
                Award Recipient :
                Funded by: National Program of Excellence
                Award ID: TÁMOP 4.2.4.A/1-11-1-2012-0001
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100007594, Univerzita Komenského v Bratislave;
                Award ID: FaF UK/19/2015
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Biochemistry
                hypercholesterolemia,autophagy,apoptosis,necroptosis,programmed necrosis,atg8,caspase,receptor-interacting serine/threonine-protein kinase

                Comments

                Comment on this article